New Strong Sell Stocks for Oct. 17th

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

Gyre Therapeutics, Inc. GYRE is a biotechnology company which is focused on organ fibrosis and inflammatory diseases. The Zacks Consensus Estimate for its current year earnings has been revised almost 69.1% downward over the last 60 days.

Darling Ingredients DAR is a provider of rendering, cooking oil and bakery waste recycling and recovery solutions. The Zacks Consensus Estimate for its current year earnings has been revised 21.7% downward over the last 60 days.

Cresco Labs Inc. CRLBF is an integrated multistate cannabis operator principally in the United States. The Zacks Consensus Estimate for its current year earnings has been revised almost 9.1 downward over the last 60 days.

View the entire Zacks Rank #5 List.

5 Stocks Set to Double

Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in the coming year. While not all picks can be winners, previous recommendations have soared +112%, +171%, +209% and +232%.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Source Zacks-com